Entrada Therapeutics Free Cash Flow (Quarterly) Analysis

Entrada Therapeutics Inc (TRDA)

18.18 -0.86 (-4.52%) USD | NASDAQ | Nov 15, 12:37

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2021. Upgrade now.

Date	Value
September 30, 2024	-24.90M
June 30, 2024	38.79M
March 31, 2024	-26.36M
December 31, 2023	-4.989M
September 30, 2023	-25.94M
June 30, 2023	-36.61M
March 31, 2023	201.73M
December 31, 2022	-28.01M

Date	Value
September 30, 2022	-28.29M
June 30, 2022	-18.78M
March 31, 2022	-21.58M
December 31, 2021	-21.86M
September 30, 2021	-14.88M
June 30, 2021	-9.454M
March 31, 2021	-9.244M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-36.61M

Minimum

Jun 2023

201.73M

Maximum

Mar 2023

-2.027M

Average

-21.58M

Median

Mar 2022

Free Cash Flow (Quarterly) Benchmarks